Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: FTSE flat as energy shares slump ahead of OPEC meeting

Thu, 27th Nov 2014 11:33

Heavy falls in the energy sector kept a lid on gains for the FTSE 100 on Thursday as investors awaited the outcome of a pivotal meeting of the Organization of Petroleum Exporting Countries (OPEC) in Vienna.London's benchmark index was up just 0.06% at 6,733 by midday. The index has traded broadly sideways since hitting a two-month high last week.While US markets will be closed for the Thanksgiving holiday, the OPEC meeting could prompt some volatility on open markets as crude prices extended a four-year low on the back of a supply glut.Brent crude fell the fourth day in London, dropping by 2.4% to $75.88 a barrel, a 50-month low, on speculation that OPEC members will not agree to a reduction in output."Each member of the oil cartel is effectively waiting for someone else to blink first, the consensus being 'we'll cut if they cut'. Whilst in theory this sounds sensible, with no one actually willing to cut, oil looks set for another precipitous fall," said analyst Connor Campbell from Spreadex."The FTSE is suffering at the hands of weak oil, due to the prevalence of energy companies making up the index," he said.Elsewhere, speeches from European Central Bank president Mario Draghi, and ECB members Jens Weidmann and Vitor Constancio were in focus on Thursday, along with data on German unemployment, inflation and consumer confidence.Energy shares slumpOil and gas producers such as BG Group, Tullow Oil, Shell, BP, Afren and Enquest were trading firmly in the red as shares tracked crude prices lower ahead of the outcome of the crucial OPEC meeting.BG Group was also feeling the heat as the proposed £25m pay package for its new boss Helge Lund continues to spark anger. The Institute of Directors branded the remuneration "excessive" and "inflammatory".Stocks in the energy services sector were also under pressure on concerns that lower prices could prompt producers to scale back on project spend. Petrofac, which delivered a profit warning to investors last week on the back of lower oil prices and the timing of contracts, was a heavy faller, along with Hunting and Amec Foster Wheeler.Amec Foster Wheeler, however, was also trading lower after going ex-dividend, meaning that investors will no longer have access to the company's latest payout. A number of stocks others also went ex-dividend on Thursday, including Dunelm, Johnson Matthey, Royal Mail, SABMiller, Vedanta Resources, Lancashire Holdings, Wolseley and JD Wetherspoon.Glaxosmithkline was subdued despite saying it is on track to complete its complex three-way £11bn deal with Swiss pharmaceutical peer Novartis next year after US regulators approved the first two parts of the transaction.Stagecoach saw shares surge after its 90%-owned joint venture with Virgin Rail won the contract from the Department for Transport to run the new InterCity East Coast franchise for eight years from March 2015.Supermarket chain J Sainsbury was under pressure after Shore Capital downgraded its rating from 'hold' to 'sell', saying investors should expect a "material contraction in profitability".Market MoverstechMARK 2,921.98 +0.36%FTSE 100 6,732.95 +0.06%FTSE 250 15,896.07 +0.68%FTSE 100 - RisersSmith & Nephew (SN.) 1,131.00p +2.17%Anglo American (AAL) 1,375.00p +2.04%ITV (ITV) 211.40p +2.03%Barclays (BARC) 242.10p +1.72%Intu Properties (INTU) 354.10p +1.64%Rio Tinto (RIO) 3,049.00p +1.57%Admiral Group (ADM) 1,233.00p +1.40%Coca-Cola HBC AG (CDI) (CCH) 1,447.00p +1.33%Mondi (MNDI) 1,083.00p +1.22%Land Securities Group (LAND) 1,187.00p +1.19%FTSE 100 - FallersPetrofac Ltd. (PFC) 874.00p -2.83%BG Group (BG.) 1,031.50p -1.72%Sainsbury (J) (SBRY) 235.10p -1.63%Morrison (Wm) Supermarkets (MRW) 178.70p -1.22%Royal Dutch Shell 'B' (RDSB) 2,339.00p -1.16%Tesco (TSCO) 185.10p -1.12%Royal Mail (RMG) 418.90p -0.99%Weir Group (WEIR) 2,038.00p -0.97%Sky (SKY) 915.50p -0.92%Rolls-Royce Holdings (RR.) 860.00p -0.81%FTSE 250 - RisersZoopla Property Group (WI) (ZPLA) 207.50p +9.10%Stagecoach Group (SGC) 397.70p +7.49%Shaftesbury (SHB) 809.50p +6.23%JD Sports Fashion (JD.) 507.00p +6.16%RPC Group (RPC) 577.00p +5.48%Riverstone Energy Limited (RSE) 905.00p +5.05%National Express Group (NEX) 252.20p +4.73%Thomas Cook Group (TCG) 118.80p +4.67%SSP Group (SSPG) 256.30p +4.61%Britvic (BVIC) 681.00p +3.97%FTSE 250 - FallersLancashire Holdings Limited (LRE) 546.50p -12.28%Amec Foster Wheeler (AMFW) 1,027.00p -3.02%EnQuest (ENQ) 63.10p -2.92%3i Infrastructure (3IN) 146.00p -2.28%Hunting (HTG) 659.50p -2.08%Afren (AFR) 63.95p -1.84%Spire Healthcare Group (SPI) 315.40p -1.59%Saga (SAGA) 154.20p -1.47%Tate & Lyle (TATE) 602.50p -1.47%Evraz (EVR) 150.30p -1.31%
More News
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.